Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
IM Cannabis Corp - SIC # 2833 - MEDICINAL CHEMICALS AND BOTANICAL PRODUCTS
Ticker
Exchange
SIC #
Website
Latest Ticker
IMCC
New York
2833
https://imcannabis.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for IM Cannabis Corp
The Flowr Corporation Announces Fourth Quarter and Full Year 2021 Results
- May 21st, 2022 12:21 am
IM Cannabis Reports Record First Quarter 2022 Financial Results; Revenues Increase 169% YoY to $23.6 Million
- May 12th, 2022 8:01 pm
IM Cannabis to Report First Quarter 2022 Financial Results on Thursday, May 12 at 5:00 p.m. ET
- May 5th, 2022 12:30 pm
OREN SHUSTER ACQUIRES COMMON SHARES OF IM CANNABIS CORP.
- Apr 12th, 2022 12:30 pm
IM Cannabis Strengthens Focus on Importing Premium and Ultra-Premium Products from its Canadian Subsidiaries
- Apr 6th, 2022 12:30 pm
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
- Apr 4th, 2022 11:00 am
IM Cannabis Reports Record Fourth Quarter and Fiscal Year 2021 Financial Results and Provides First Quarter 2022 Outlook
- Mar 31st, 2022 12:00 pm
IM Cannabis Closes Previously Announced Acquisition of Oranim Pharm, Jerusalem's Leading Medical Cannabis Pharmacy
- Mar 30th, 2022 12:30 pm
IM Cannabis Reschedules Fourth Quarter and Full Year 2021 Conference Call to Thursday, March 31 at 9:00 a.m. ET
- Mar 29th, 2022 12:30 pm
IM Cannabis to Report Fourth Quarter and Full Year 2021 Financial Results on Wednesday, March 30 at 9:00 a.m. ET
- Mar 23rd, 2022 12:00 pm
IM Cannabis Closes Three Previously Announced Strategic Acquisitions in Israel
- Mar 15th, 2022 12:00 pm
IM Cannabis Reports Record Preliminary Fourth Quarter and Full Year 2021 Financial Results
- Mar 10th, 2022 1:00 pm
IM Cannabis Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communications Program
- Feb 8th, 2022 1:00 pm
AdvisorShares Investments LLC Buys Invesco NASDAQ 100 ETF, AdvisorShares Pure US Cannabis ETF, ...
- Jan 31st, 2022 10:38 pm
Cannabis Industry Investor Presentations Now Available for On-Demand Viewing
- Jan 24th, 2022 1:35 pm
IM Cannabis announces Focus Medical's Import of 400 Kilograms of Premium-Indoor-Grown Dried Cannabis from Canada to Israel
- Jan 19th, 2022 1:30 pm
Cannabis Industry Investor Conference: Company Executives Present January 19th & 20th
- Jan 18th, 2022 5:35 am
The Flowr Corporation Announces International Commercialization of Its Flagship Strains – BC Black Cherry and BC Strawnana
- Jan 13th, 2022 11:00 pm
IM Cannabis Corp. Appoints Rinat Efrima as New Chief Executive Officer of IMC Holdings, the Company’s Israeli Subsidiary
- Jan 13th, 2022 1:00 pm
IM Cannabis to Launch WAGNERS Brand in Germany
- Dec 7th, 2021 2:00 pm
Scroll